Skip to content
Assyro AI

FDA PDUFA dates in October 2026

Published PDUFA target action dates for NDAs, BLAs, ANDAs, and INDs scheduled in October 2026, sourced from FDA primary records.

Tracking 10 published FDA PDUFA decisions, including 4 NDAs and 6 BLAs.

FDA PDUFA dates in October 2026: 10 published FDA PDUFA target action dates. Select a row to expand its full record.
SponsorProductTypeApplicationPDUFA dateStatusAsk, copy and expand
Merck and EisaiWELIREG + LENVIMANDANDA 215383 SUPPL-13decided
Genentech (Roche)Tecentriq (atezolizumab)BLAPENDING-provisional|genentechroche|tecentriqatezolizumaboverdue
Genentech (Roche)Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs)BLAPENDING-provisional|genentechroche|tecentriqhybrezaatezooverdue
Daiichi Sankyo and Merckifinatamab deruxtecanBLAPENDING-provisional|daiichisankyoandmerck|ifinatamabderuoverdue
Genentech / RocheEnspryng (satralizumab)BLAPENDING-provisional|genentechroche|enspryngsatralizumab|overdue
Opus Genetics and Viatrisphentolamine ophthalmic solution 0.75%NDAPENDING-provisional|opusgeneticsandviatris|phentolamineooverdue
PHARMINGJOENJANDANDA 217759 SUPPL-6decided
GSKbepirovirsenNDAPENDING-provisional|gsk|bepirovirsen|chronichepatitisb|2overdue
Sun Pharmaceutical IndustriesILUMYA (tildrakizumab-asmn)BLAPENDING-provisional|sunpharmaceuticalindustries|ilumyatioverdue
INOVIO PharmaceuticalsINO-3107BLAPENDING-provisional|inoviopharmaceuticals|ino3107|recurroverdue

Select any row to expand its full record. Use the calendar, timeline, status board, or table views above to filter, sort, and inspect source-linked details.

October 2026 FDA PDUFA Calendar: Drug Approval Dates & Deadlines

Track October 2026 FDA review dates and drug approval decisions. Browse products, sponsors, application types, source-linked deadlines, and reported outcomes.

Loading calendar controls…